These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6716275)

  • 1. Pharmacokinetic-pharmacodynamic modeling of prednisolone-induced lymphocytopenia in man.
    Oosterhuis B; ten Berge RJ; Sauerwein HP; Endert E; Schellekens PT; van Boxtel CJ
    J Pharmacol Exp Ther; 1984 May; 229(2):539-46. PubMed ID: 6716275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prednisolone concentration-effect relations in humans and the influence of plasma hydrocortisone.
    Oosterhuis B; ten Berge IJ; Schellekens PT; Koopmans RP; van Boxtel CJ
    J Pharmacol Exp Ther; 1986 Dec; 239(3):919-26. PubMed ID: 3795051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concentration-dependent effects of prednisolone on lymphocyte subsets and mixed lymphocyte culture in humans.
    Oosterhuis B; ten Berge IJ; Schellekens PT; van Boxtel CJ
    J Pharmacol Exp Ther; 1987 Nov; 243(2):716-22. PubMed ID: 2960797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanism-based PK/PD model for the lymphocytopenia induced by endogenous and exogenous corticosteroids.
    Meibohm B; Derendorf H; Möllmann H; Fröhlich P; Tromm A; Wagner M; Homrighausen S; Krieg M; Hochhaus G
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):367-76. PubMed ID: 10475139
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetic-dynamic modeling of lymphocytopenia induced by the combined action of dexamethasone and hydrocortisone in humans, after inhalation and intravenous administration of dexamethasone.
    Braat MC; Oosterhuis B; Koopmans RP; Meewis JM; Van Boxtel CJ
    J Pharmacol Exp Ther; 1992 Aug; 262(2):509-15. PubMed ID: 1501111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of infusion rate on thiopental dose-response relationships. Assessment of a pharmacokinetic-pharmacodynamic model.
    Gentry WB; Krejcie TC; Henthorn TK; Shanks CA; Howard KA; Gupta DK; Avram MJ
    Anesthesiology; 1994 Aug; 81(2):316-24; discussion 25A. PubMed ID: 8053580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic modeling of lymphocytopenia and whole blood lymphocyte cultures in prednisolone-treated individuals.
    Bloemena E; Koopmans RP; Weinreich S; van Boxtel CJ; Schellekens PT
    Clin Immunol Immunopathol; 1990 Dec; 57(3):374-86. PubMed ID: 2147133
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic interaction between endogenous cortisol and exogenous corticosteroids.
    Rohatagi S; Hochhaus G; Möllmann H; Barth J; Derendorf H
    Pharmazie; 1995 Sep; 50(9):610-3. PubMed ID: 7480097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetic/pharmacodynamic modelling of effects of dexamethasone and prednisolone in combination with endogenous cortisol on lymphocyte counts and systemic markers of bone turn over and inflammation in healthy and asthmatic men.
    Dubois EF; Derks MG; Schweitzer DH; Zwinderman AH; Dekhuijzen PN; van Boxtel CJ
    Eur J Clin Pharmacol; 2004 Jul; 60(5):315-28. PubMed ID: 15150679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversible metabolism and pharmacokinetics: application to prednisone-prednisolone.
    Wagner JG; DiSanto AR; Gillespie WR; Albert KS
    Res Commun Chem Pathol Pharmacol; 1981 Jun; 32(3):387-405. PubMed ID: 7268190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic and pharmacodynamic modeling of mizolastine in healthy volunteers with an indirect response model.
    Deschamps C; Dubruc C; Mentre F; Rosenzweig P
    Clin Pharmacol Ther; 2000 Dec; 68(6):647-57. PubMed ID: 11180025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of two different hydrocortisone doses on human peripheral blood lymphocyte nucleologram.
    Malacarne P; Marzola M; Santini A; Indelli M
    Folia Biol (Praha); 1989; 35(1):13-8. PubMed ID: 2714498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacodynamic and pharmacokinetic properties of an angiotensin II receptor antagonist--characterization by use of Schild regression technique in man.
    Breithaupt-Grögler K; Malerczyk C; Belz GG; Butzer R; Herrmann V; Stass H; Wensing G
    Int J Clin Pharmacol Ther; 1997 Oct; 35(10):434-41. PubMed ID: 9352392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antagonistic effect of heparin and a water-soluble glucocorticoid on the peripheral lymphocyte count in mice.
    Jókay I; Karczag E
    Haematologia (Budap); 1977; 11(1-2):103-10. PubMed ID: 615083
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The influence of prednisolone on the recirculation of peripheral blood lymphocytes in vivo.
    Bloemena E; Weinreich S; Schellekens PT
    Clin Exp Immunol; 1990 Jun; 80(3):460-6. PubMed ID: 2115420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nociceptive stimulus modality-related difference in pharmacokinetic-pharmacodynamic modeling of morphine in the rat.
    Shang GW; Liu DN; Yan LH; Cui XY; Zhang KP; Qi C; Chen J
    Pharmacol Biochem Behav; 2006 Oct; 85(2):464-73. PubMed ID: 17126387
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic-pharmacodynamic modeling of morphine and oxycodone concentrations and analgesic effect in a multimodal experimental pain model.
    Staahl C; Upton R; Foster DJ; Christrup LL; Kristensen K; Hansen SH; Arendt-Nielsen L; Drewes AM
    J Clin Pharmacol; 2008 May; 48(5):619-31. PubMed ID: 18440921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of alternate-day prednisolone administration on hypophyseal-adrenocortical activity in dogs.
    Brockus CW; Dillon AR; Kemppainen RJ
    Am J Vet Res; 1999 Jun; 60(6):698-702. PubMed ID: 10376895
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic-pharmacodynamic modeling of the anticonvulsant and electroencephalogram effects of phenytoin in rats.
    Della Paschoa OE; Mandema JW; Voskuyl RA; Danhof M
    J Pharmacol Exp Ther; 1998 Feb; 284(2):460-6. PubMed ID: 9454785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic assessments of the dipeptidyl peptidase-4 inhibitor PHX1149: double-blind, placebo-controlled, single- and multiple-dose studies in healthy subjects.
    O'Farrell AM; van Vliet A; Abou Farha K; Cherrington JM; Campbell DA; Li X; Hanway D; Li J; Guler HP
    Clin Ther; 2007 Aug; 29(8):1692-705. PubMed ID: 17919550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.